相关实验视频
Updated: Feb 20, 2026

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
19.0K
蛋白在阿尔茨海默氏病中的交互合作伙伴
Subashchandrabose Chinnathambi1, Gowshika Velmurugan1, Murugappan Kumarappan1
1Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences Hospital (NIMHANS), Institute of National Importance, Bangalore, Karnataka, India.
Advances in clinical chemistry
|February 18, 2026
概括
阿尔茨海默病涉及tau蛋白聚合和高酸化,导致神经退行. 了解相互作用是开发治疗这种认知衰退条件的关键.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,其特点是记忆力丧失和认知能力下降.
- 蛋白的细胞内聚合成神经纤维状 (NFT) 是AD的一个标志,损害神经元功能.
- 陶是一种与微管相关的蛋白质,它本质上是无序的,并且在微管稳定中发挥作用.
研究的目的:
- 审查tau作为一个多功能蛋白质.
- 探索的交互伙伴及其在生理和病理条件中的作用.
- 了解相互作用如何影响阿尔茨海默病的疾病进展和神经保护.
主要方法:
- 对陶蛋白相互作用的文献综述.
- 分析陶氏在微管力学中的作用.
- 检查中枢神经系统中tau的翻译后修改.
主要成果:
- 与众多蛋白质相互作用,影响正常功能和病理变化.
- 相互作用可以传播病原体或产生神经保护作用.
- 高酸化和tau的聚合是AD的关键病理标志物.
结论:
- 是阿尔茨海默氏症病原发生的核心参与者.
- 识别tau的交互合作伙伴为治疗策略提供了洞察力.
- 对陶氏多方面的作用进行进一步的研究对于理解和治疗AD至关重要.
相关概念视频
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Alzheimer's Disease: Treatment
1.0K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.0K
Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Microtubule Associated Proteins (MAPs)
6.0K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
6.0K
Enzyme-linked Receptors
87.0K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
87.0K

